Applied DNA Sciences, Inc.
APDN
$0.1314
$0.00181.39%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -138.84% | 8.23% | 160.64% | -859.90% | 71.25% |
| Total Depreciation and Amortization | -80.40% | -76.65% | -61.56% | -45.92% | -11.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 90.05% | 188.96% | -836.93% | 134.45% | -195.44% |
| Change in Net Operating Assets | 18.18% | -125.23% | -151.19% | -98.68% | 52.17% |
| Cash from Operations | 11.49% | -21.24% | -155.24% | -1,597.20% | -57.68% |
| Capital Expenditure | -- | 59.85% | 86.53% | 72.74% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 59.85% | 86.53% | 72.74% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13,729.39% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18,066.38% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 175.49% | -11.28% | 576.32% | -230.88% | -62.22% |
